Related references
Note: Only part of the references are listed.Functional Capacity of Shiga-Toxin Promoter Sequences in Eukaryotic Cells
Leticia V. Bentancor et al.
PLOS ONE (2013)
Promoter Sequence of Shiga Toxin 2 (Stx2) Is Recognized In Vivo, Leading to Production of Biologically Active Stx2
Leticia V. Bentancor et al.
MBIO (2013)
Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals
Chad L. Mayer et al.
TOXINS (2012)
Comparison of a bacteriophage-delivered DNA vaccine and a commercially available recombinant protein vaccine against hepatitis B
Jason R. Clark et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2011)
Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration
Maurizio Brigotti et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors
Christian H. Schweppe et al.
JOURNAL OF LIPID RESEARCH (2010)
Interactions of Shiga-like toxin with human peripheral blood monocytes
Joyce M. Geelen et al.
PEDIATRIC NEPHROLOGY (2007)
Phage regulatory circuits and virulence gene expression
MK Waldor et al.
CURRENT OPINION IN MICROBIOLOGY (2005)
Serum amyloid P component is the shiga toxin 2-neutralizing factor in human blood
T Kimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Platelet activation by Shiga toxin and circulatory factors as a pathogenetic mechanism in the hemolytic uremic syndrome
D Karpman et al.
BLOOD (2001)
Share Paper
